SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000882104-15-000023
Filing Date
2015-03-11
Accepted
2015-03-11 16:32:36
Documents
7
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pdli-20141231x10kadoc.htm 10-K/A 41020
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM pdli-20141231x10kaex231.htm EX-23.1 7034
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM pdli-20141231x10kaex232.htm EX-23.2 7592
4 CERTIFICATION pdli-20141231x10kaex311.htm EX-31.1 5852
5 CERTIFICATION pdli-20141231x10kaex312.htm EX-31.2 5853
6 CERTIFICATION pdli-20141231x10kaex32.htm EX-32 13925
7 pdl-logoa06.jpg GRAPHIC 59351
  Complete submission text file 0000882104-15-000023.txt   164278
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19756 | Film No.: 15693136
SIC: 2836 Biological Products, (No Diagnostic Substances)